EN

Sección de utilidades

Calendar

Fin de la sección de utilidades

Events

Start of main content

Xenotransplant. Solution for the future?

Life and Matter Sciences International Meeting February 9 - 10, 1999 Madrid

In the past years the development of tissue and organ transplants has been such both in number and in results obtained, that the demand of these types of therapies has grown enormously, creating an important disproportion between the offer of available organs and tissues and the created needs.

Organized by:

Fundación Ramón Areces

Coordinator/s:

Director: 
Rafael MatesanzPresidente. Comisión de Trasplantes del Consejo Interterritorial del Sistema Nacional de Salud. Madrid.

Blanca MirandaCoordinadora Nacional de Trasplantes.
Organización Nacional de Trasplantes (ONT). Madrid.

Rafael MañezDirector. Medicina del Trasplante.
Hospital Juan Canalejo. La Coruña.

  • Description
  • Programme

The scientific community has been considering xenotransplantation as a possible solution to this problem for a long time. In fact, several research teams dedicate their efforts to this interesting field.

Despite the undeniable therapy possibilities which have been brought about a priori, there exists an evident international concern related to the outcome of the research being carried out, more specifically related to an hypothetical clinical phase or even to an established clinical application:

  • The future behaviour of animal infectious agents in the human being and viceverse remains unknown.
  • The functional viability of organs from animal origin, both from a qualitative point of view as well as the average duration of this function, is unknown.
  • There are no specific regulations for xenotransplantation practices, neither at a national nor at an international level. Furthermore, there are no clear ethical statements of this issue, although different national and international bodies are publishing several documents and recommendations.
  • The psychosocial impact of an eventual clinical phase also remains unknown.

All those questions had pushed us to promote this Symposium with the aim of opening the debate going deeply in the current knowledge on this field. We hope that the participation of the people who is in first line of the investigations on xenotransplantation will be of grateful help to achieve this aim.

Tuesday, 9 - Wednesday, 10

 

Participants

Enrique Castellón
Subsecretario de Sanidad y Consumo.
Ministerio de Sanidad y Consumo.

Rafael Matesanz
Jose María Segovia de Arana.
Presidente del Consejo Asesor de Sanidad.
Ministerio de Sanidad y Consumo.

Pascual Parrilla
Hospital Virgen de la Arrixaca.
Murcia.

Manuel Arias
Hospital Universitario Marqués de Valdecilla.
Santander.

Gilda Pino Chavez
Imutran Limited. University of Cambridge.
Cambridge. Reino Unido.

Jeff L. Platt
Mayo Clinic.
Rochester. EE.UU.

Robert I
Lechler. Hammersmith Hospital.
Londres. Reino Unido.

Santiago Grisolía
Instituto de Investigaciones Citológicas.
Valencia.

Megan Sykes
Massachusetts General Hospital.
Boston. EE.UU.

Mª Antonia Viedma
OCATT.
Barcelona.

Kate Darwin
Wellington House.
Londres. Reino Unido.

Javier Sánchez Caro
Asesoría Jurídica.
INSALUD.
Madrid.

José Mª. Griñó
Hospital de Bellvitge.
Barcelona.

Carlos Lumbreras
Hospital Universitario Doce de Octubre
Madrid.

Rafael Nájera
Centro Nacional de Biología Fundamental
Madrid.

Diego Gracia
Facultad de Medicina.
Universidad Complutense.
Madrid.

Francesc Abel
Institut Borja de Bioética
Barcelona.

  • Activities related
  • Projects related
  • News related
  • Publications related

see past activities

see all

End of main content